Skip to main content

#161702

Anti-CD98 monoclonal antibody [GRV1]

Cat. #161702

Anti-CD98 monoclonal antibody [GRV1]

Cat. #: 161702

Sub-type: Primary antibody

Availability: 3-4 weeks

Target: CD98

Class: Monoclonal

Application: FACS; IHC; ELISA; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Francisco Ruíz-Cabello Osuna, Miguel Ángel López-Nevot and Federico Garrido Torres-Puchol

Institute: Virgen de las Nieves University Hospital, The Andalusian Health Service

Primary Citation: Springer et al. 1995. Leukocyte Typing V. 1443-1467.

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD98 monoclonal antibody [GRV1]
  • Research fields: Cell signaling and signal transduction
  • Clone: GRV1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Molecular weight: 120 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS; IHC; ELISA; WB
  • Description: CD98 is part of a family of proteins9 that associate to form functional amino acid transporters by associating with LAT-1 and LAT-2 proteins. CD98 expression on many actively proliferating cells, including epithelial and fibroblastic cells, and by activated leucocytes at sites of inflammation, suggests involvement in cell activation and proliferation
  • Immunogen: KM3 cell
  • Isotype: IgG1k
  • Recommended controls: KM3

Target Details

  • Target: CD98
  • Molecular weight: 120 kDa

Applications

  • Application: FACS; IHC; ELISA; WB

Handling

  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Springer et al. 1995. Leukocyte Typing V. 1443-1467.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.